Article Details

Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein ...

Retrieved on: 2021-02-19 21:47:46

Tags for this article:

Click the tags to see associated articles and topics

Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein .... View article details on hiswai:

Excerpt

Monoclonal antibodies against the SARS-CoV-2 spike protein, notably, those developed by Regeneron Pharmaceuticals and Eli Lilly and Company ...

Article found on: www.biorxiv.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up